Tapan BhattacharyyaAndrew K. FalconarAlejandro O. LuquettiJaime A. CostalesMario J. GrijalvaMichael D. LewisLouisa A. MessengerTrang T. TranJuan David RamÃrezFelipe Guhl2026-03-222026-03-22201410.1371/journal.pntd.0002892https://doi.org/10.1371/journal.pntd.0002892https://andeanlibrary.org/handle/123456789/44603Citaciones: 53These results demonstrate the considerable potential for synthetic peptide serology to investigate the infection history of individuals, geographical and clinical associations of T. cruzi lineages.enChagas diseaseEpitopeTrypanosoma cruziSerologyVirologyBiologyGenotypingAntibodyChronic infectionAntigenDevelopment of Peptide-Based Lineage-Specific Serology for Chronic Chagas Disease: Geographical and Clinical Distribution of Epitope Recognitionarticle